Grady Jason 4

What Happened

• Director Grady Jason reported the sale of 50,000 shares of Impact Biomedical, Inc. (IBO) on 2026-03-23. The shares were disposed at $0.65 per share for total proceeds of $32,505. The filing indicates the transaction type as an open market or private sale (code S).

Key Details

• Transaction date: 2026-03-23; Filing date: 2026-03-25 (filed within the typical two-business-day Form 4 window).
• Price: $0.65 per share; Total proceeds: $32,505.
• Shares owned after the transaction: Not specified in the provided filing summary.
• Remark on reporting entity: The filing notes the selling entity is a wholly-owned subsidiary of DSS, Inc.
• Transaction code: S = Sale (disposition). No 10b5-1 plan, tax withholding, or other special footnotes were indicated in the provided summary.

Context

• This was a sale (disposition), which is often routine and does not by itself indicate management’s view of the company’s prospects. No option exercise, gift, or award was reported in this transaction.